Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013 (2013), Article ID 186041, 12 pages
http://dx.doi.org/10.1155/2013/186041
Research Article

Circulating C19MC MicroRNAs in Preeclampsia, Gestational Hypertension, and Fetal Growth Restriction

1Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, Ruska 87, 100 00 Prague, Czech Republic
2Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, Podolske Nabrezi 157/36, 147 00 Prague, Czech Republic
3Clinic of Obstetrics and Gynecology, Second Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague, Czech Republic

Received 22 July 2013; Revised 24 September 2013; Accepted 30 September 2013

Academic Editor: Jyoti J. Watters

Copyright © 2013 Ilona Hromadnikova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. G. Redman and I. L. Sargent, “Preeclampsia and the systemic inflammatory response,” Seminars in Nephrology, vol. 24, no. 6, pp. 565–570, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Nelson, “Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast,” Placenta, vol. 17, no. 7, pp. 387–391, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. C. B. M. Oudejans, M. L. Tjoa, B. A. Westerman, M. A. M. Mulders, I. J. Van Wijk, and J. M. G. Van Vugt, “Circulating trophoblast in maternal blood,” Prenatal Diagnosis, vol. 23, no. 2, pp. 111–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Huppertz and J. C. P. Kingdom, “Apoptosis in the trophoblast—role of apoptosis in placental morphogenesis,” Journal of the Society for Gynecologic Investigation, vol. 11, no. 6, pp. 353–362, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. F. Orozco, F. Z. Bischoff, C. Horne, E. Popek, J. L. Simpson, and D. E. Lewis, “Hypoxia-induced membrane-bound apoptotic DNA particles: potential mechanism of fetal DNA in maternal plasma,” Annals of the New York Academy of Sciences, vol. 1075, pp. 57–62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Hromadnikova, “Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency,” DNA and Cell Biology, vol. 31, no. 7, pp. 1221–1232, 2012. View at Google Scholar
  7. C. W. Redman and I. L. Sargent, “Latest advances in understanding preeclampsia,” Science, vol. 308, no. 5728, pp. 1592–1594, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Y. Khong, F. De Wolf, W. B. Robertson, and I. Brosens, “Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants,” British Journal of Obstetrics and Gynaecology, vol. 93, no. 10, pp. 1049–1059, 1986. View at Google Scholar · View at Scopus
  9. WHO, “World Health Organization International Collaborative Study of Hypertensive Disorders in Pregnancy. Geographic variation in the incidence of hypertension in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 158, no. 1, pp. 80–83, 1988. View at Google Scholar
  10. J. E. Bamfo and A. O. Odibo, “Diagnosis and management of fetal growth restriction,” Journal of Pregnancy, vol. 2011, Article ID 640715, 15 pages, 2011. View at Publisher · View at Google Scholar
  11. ACOG Committee on Practise Bulletins-Obstetrics, “Diagnosis and management of preeclampsia and eclampsia,” Obstetrics and Gynecology, vol. 99, no. 1, pp. 159–167, 2002. View at Google Scholar
  12. K. S. Khan, D. Wojdyla, L. Say, A. M. Gülmezoglu, and P. F. Van Look, “WHO analysis of causes of maternal death: a systematic review,” The Lancet, vol. 367, no. 9516, pp. 1066–1074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Germain, G. P. Sacks, S. R. Soorana, I. L. Sargent, and C. W. Redman, “Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles,” Journal of Immunology, vol. 178, no. 9, pp. 5949–5956, 2007. View at Google Scholar
  14. A. Reddy, X. Y. Zhong, C. Rusterholz et al., “The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia,” Placenta, vol. 29, no. 11, pp. 942–949, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. L. C. Y. Poon, R. Akolekar, R. Lachmann, J. Beta, and K. H. Nicolaides, “Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks,” Ultrasound in Obstetrics and Gynecology, vol. 35, no. 6, pp. 662–670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Akolekar, A. Syngelaki, R. Sarquis, M. Zvanca, and K. H. Nicolaides, “Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks,” Prenatal Diagnosis, vol. 31, no. 1, pp. 66–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. von Dadelszen, L. A. Magee, and J. M. Roberts, “Subclassification of preeclampsia,” Hypertension in Pregnancy, vol. 22, no. 2, pp. 143–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Huppertz, “Placental origins of preeclampsia: challenging the current hypothesis,” Hypertension, vol. 51, no. 4, pp. 970–975, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Valensise, B. Vasapollo, G. Gagliardi, and G. P. Novelli, “Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease,” Hypertension, vol. 52, no. 5, pp. 873–880, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. M. Dennis Lo, N. Corbetta, P. F. Chamberlain et al., “Presence of fetal DNA in maternal plasma and serum,” The Lancet, vol. 350, no. 9076, pp. 485–487, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Smid, A. Vassallo, F. Lagona et al., “Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities,” Annals of the New York Academy of Sciences, vol. 945, pp. 132–137, 2001. View at Google Scholar · View at Scopus
  22. E. Caramelli, N. Rizzo, M. Concu et al., “Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction—a pilot study,” Prenatal Diagnosis, vol. 23, no. 5, pp. 367–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-M. Costa, A. Benachi, and E. Gautier, “New strategy for prenatal diagnosis of X-linked disorders,” New England Journal of Medicine, vol. 346, no. 19, p. 1502, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Rijnders, C. E. van der Schoot, B. Bossers, M. A. de Vroede, and G. C. Christiaens, “Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia,” Obstetetrics and Gynecology, vol. 98, no. 3, pp. 374–378, 2001. View at Google Scholar
  25. B. H. W. Faas, E. A. Beuling, G. C. M. L. Christiaens, A. E. G. K. Von Dem Borne, and C. E. Van Der Schoot, “Detection of fetal RHD-specific sequences in maternal plasma,” The Lancet, vol. 352, no. 9135, p. 1196, 1998. View at Google Scholar · View at Scopus
  26. Y. M. D. Lo, N. M. Hjelm, C. Fidler et al., “Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma,” New England Journal of Medicine, vol. 339, no. 24, pp. 1734–1738, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Hromadnikova, L. Vechetova, K. Vesela, B. Benesova, J. Doucha, and R. Vlk, “Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies,” Journal of Histochemistry and Cytochemistry, vol. 53, no. 3, pp. 301–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. K. C. A. Chan, C. Ding, A. Gerovassili et al., “Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis,” Clinical Chemistry, vol. 52, no. 12, pp. 2211–2218, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. M. D. Lo, T. N. Leung, M. S. C. Tein et al., “Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia,” Clinical Chemistry, vol. 45, no. 2, pp. 184–188, 1999. View at Google Scholar · View at Scopus
  30. T.-W. Lau, T. N. Leung, L. Y. S. Chan et al., “Fetal DNA clearance from maternal plasma is impaired in preeclampsia,” Clinical Chemistry, vol. 48, no. 12, pp. 2141–2146, 2002. View at Google Scholar · View at Scopus
  31. B. M. Byrne, A. Crowley, F. Taulo, J. Anthony, J. J. O'Leary, and C. O'Herlihy, “Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia,” Hypertension in Pregnancy, vol. 22, no. 2, pp. 157–164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Sekizawa, M. Jimbo, H. Saito et al., “Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction,” American Journal of Obstetrics and Gynecology, vol. 188, no. 2, pp. 480–484, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. D. W. Y. Tsui, K. C. A. Chan, S. S. C. Chim et al., “Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia,” Prenatal Diagnosis, vol. 27, no. 13, pp. 1212–1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Hromadnikova, M. Benesova, L. Zejskova et al., “The effect of DYS-14 copy number variations on extracellular fetal DNA quantification in maternal circulation,” DNA and Cell Biology, vol. 28, no. 7, pp. 351–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Hromadnikova, L. Zejskova, K. Kotlabova et al., “Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences—evaluation of diagnostic possibilities for predicting placental insufficiency,” DNA and Cell Biology, vol. 29, no. 6, pp. 295–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. B. L. Pineles, R. Romero, D. Montenegro et al., “Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia,” American Journal of Obstetrics and Gynecology, vol. 196, no. 3, pp. 261.e1–261.e6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. X.-M. Zhu, T. Han, I. L. Sargent, G.-W. Yin, and Y.-Q. Yao, “Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies,” American Journal of Obstetrics and Gynecology, vol. 200, no. 6, pp. 661.e1–661.e7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Hu, P. Li, S. Hao, L. Liu, J. Zhao, and Y. Hou, “Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia,” Clinical Chemistry and Laboratory Medicine, vol. 47, no. 8, pp. 923–929, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. S. C. Chim, T. K. F. Shing, E. C. W. Hung et al., “Detection and characterization of placental microRNAs in maternal plasma,” Clinical Chemistry, vol. 54, no. 3, pp. 482–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. E. C. Lai, “Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation,” Nature Genetics, vol. 30, no. 4, pp. 363–364, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Gunel, Z. G. Zeybek, P. Akçakaya et al., “Serum microRNA expression in pregnancies with preeclampsia,” Genetics and Moecular Research, vol. 10, no. 4, pp. 4034–4040, 2011. View at Google Scholar
  43. Q. Yang, J. Lu, S. Wang, H. Li, Q. Ge, and Z. Lu, “Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women,” Clinica Chimica Acta, vol. 412, no. 23-24, pp. 2167–2173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Wu, H. Zhou, H. Lin et al., “Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies,” Reproduction, vol. 143, no. 3, pp. 389–397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J.-F. Mouillet, T. Chu, C. A. Hubel, D. M. Nelson, W. T. Parks, and Y. Sadovsky, “The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction,” Placenta, vol. 31, no. 9, pp. 781–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Seitz, H. Royo, M.-L. Bortolin, S.-P. Lin, A. C. Ferguson-Smith, and J. Cavaillé, “A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain,” Genome Research, vol. 14, no. 9, pp. 1741–1748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Liang, D. Ridzon, L. Wong, and C. Chen, “Characterization of microRNA expression profiles in normal human tissues,” BMC Genomics, vol. 8, article 166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Bentwich, A. Avniel, Y. Karov et al., “Identification of hundreds of conserved and nonconserved human microRNAs,” Nature Genetics, vol. 37, no. 7, pp. 766–770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Lin, W. K. C. Cheung, S. Chen et al., “Computational identification and characterization of primate-specific microRNAs in human genome,” Computational Biology and Chemistry, vol. 34, no. 4, pp. 232–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. D. M. Morales-Prieto, S. Ospina-Prieto, W. Chaiwangyen, M. Schoenleben, and U. R. Markert, “Pregnancy-associated miRNA-clusters,” Journal of Reproductive Immunology, vol. 97, no. 1, pp. 51–61, 2013. View at Google Scholar
  51. K. Kotlabova, J. Doucha, and I. Hromadnikova, “Placental-specific microRNA in maternal circulation—identification of appropriate pregnancy-associated microRNAs with diagnostic potential,” Journal of Reproductive Immunology, vol. 89, no. 2, pp. 185–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M.-L. Bortolin-Cavaille, M. Dance, M. Weber, and J. Cavaille, “C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts,” Nucleic Acids Research, vol. 37, no. 10, pp. 3464–3473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. MiRNAMap 2.0 [Internet], Department of Biological Science and Technology, Institute of Bioinformatics National Chiao Tung University, Hsinchu, Taiwan, 2013, http://mirnamap.mbc.nctu.edu.tw.
  54. I. Hromadnikova, K. Kotlabova, J. Doucha, K. Dlouha, and L. Krofta, “Absolute and relative quantification of placenta-specific microRNAs in maternal circulation with placental insufficiency—related complications,” Journal of Molecular Diagnostics, vol. 14, no. 2, pp. 160–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. M. A. Maccani, J. F. Padbury, and C. J. Marsit, “miR-16 and miR-21 expression in the placenta is associated with fetal growth,” PLoS ONE, vol. 6, no. 6, Article ID e21210, 2011. View at Publisher · View at Google Scholar · View at Scopus